Related Experiment Video

Updated: Jun 28, 2026

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model
06:02

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model

Published on: November 6, 2020

[Our efforts to curb systemic fungal infections]

Koichi Izumikawa1, Shigeru Kohno

  • 1Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan.

Nihon Ishinkin Gakkai Zasshi = Japanese Journal of Medical Mycology
|November 13, 2008
PubMed

Insights

Systemic fungal infections (SFIs) are rising in immunocompromised patients. Research aims to improve diagnostics for aspergillosis and find new treatments for fungal infections like candidiasis and cryptococcosis.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunocompromised Host Research

Context:

  • Increasing incidence of systemic fungal infections (SFIs) due to rising immunocompromised populations.
  • Major etiologies include Aspergillus, Candida, and Cryptococcus, with a notable rise in aspergillosis.
  • SFIs present challenges including low diagnostic rates and poorer prognoses compared to other pathogens.

Purpose:

  • To address critical issues in SFIs, including low diagnostic rates and treatment efficacy.
  • To develop novel rapid diagnostic tools for aspergillosis.
  • To establish clinical trials for chronic aspergillosis and explore new therapeutic strategies.

Summary:

  • Focus on improving diagnostics and treatments for key SFIs: aspergillosis, candidiasis, and cryptococcosis.
  • Aims include developing rapid aspergillosis diagnostics, advancing chronic aspergillosis treatment, and identifying Cryptococcus virulence factors.
  • Research will also evaluate alternative treatments for azole-resistant Candida infections.

Impact:

  • Advances in diagnostics and treatment will improve patient outcomes for SFIs.
  • Enhanced understanding of fungal pathogenesis will guide future therapeutic development.
  • This research aims to reduce the morbidity and mortality associated with systemic fungal infections.

More Related Videos

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...